Menu

Star on GitHub · 3.2k

CVE-2022-29523

3.3 · LOW

Improper conditions check in the Open CAS software maintained by Intel(R) before version 22.3.1 may allow an authenticated user to potentially enable denial of service via local access.

Published Feb 16, 2023CWE-754EPSS 0.18%

Overview

CVE-2022-29523 is a low-severity vulnerability. It was published on February 16, 2023 and has a CVSS 3.1 base score of 3.3 (LOW).

This vulnerability has a CVSS 3.1 base score of 3.3, rated LOW. It requires local or adjacent network access to exploit. Some level of privileges is required for exploitation.

Technical description

Improper conditions check in the Open CAS software maintained by Intel(R) before version 22.3.1 may allow an authenticated user to potentially enable denial of service via local access.

Remediation

Check the references section for vendor advisories, patches, and mitigation guidance. If immediate patching is not possible, review the CVSS vector to understand the attack surface and apply compensating controls such as network segmentation or access restrictions.

Frequently asked questions

What is CVE-2022-29523?

CVE-2022-29523 is a low-severity vulnerability. It was published on February 16, 2023 and has a CVSS 3.1 base score of 3.3 (LOW).

How severe is CVE-2022-29523?

This vulnerability has a CVSS 3.1 base score of 3.3, rated LOW. It requires local or adjacent network access to exploit. Some level of privileges is required for exploitation.

How do I fix or remediate CVE-2022-29523?

Check the references section for vendor advisories, patches, and mitigation guidance. If immediate patching is not possible, review the CVSS vector to understand the attack surface and apply compensating controls such as network segmentation or access restrictions.

How can CyberStrike help with CVE-2022-29523?

CyberStrike is an open-source, AI-augmented pentesting engine. Rather than flag a version number, it tests whether an issue like CVE-2022-29523 is actually reachable in your own applications and APIs, then verifies each finding before reporting it. That tells you if the weakness is a real, exploitable risk in your environment or a false positive you can safely deprioritize.

Related LOW CVEs from 2022

View all